It is time to rethink traditional approaches to biosafety.

Only when greater transparency is established in supply chains can the industry begin to iron out problems with drug shortages.

What needs to change to improve our odds in the fight against AMR?

Researchers seek a way to inactivate CAR-T cells in case of adverse effects.

We announce a new Special Series of articles devoted to advanced medicine.

It's time to vote for the grand winner of The Medicine Maker Innovation Awards.

What's new in business?

What type of dosage form would a patient prefer to take? Additive manufacturing provides the ultimate flexibility.

Why virtual and augmented reality technologies are the future of workforce training.

If we learn more about drug–nutrient interactions, we may be on the path towards better medicines.